Stock-Based Compensation

3 Months Ended

Oct. 27, 2012

Stock-Based Compensation [Abstract]

Stock-Based Compensation

5.           Stock-Based Compensation

The compensation costs that have been charged against income for the thirteen and thirty-nine weeks ended October 27, 2012 and October 29, 2011 were as follows (in thousands):

	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	October 27,		October 29,		October 27,		October 29,
	2012		2011		2012		2011
Stock-based compensation expense by type:
Stock options	$	32	$	19	$	774	$	442
Restricted stock unit awards, including performance-based		1,024		1,594		3,978		4,214
Employee stock purchase		16		19		51		60
Director deferred compensation		15		15		21		45
Total stock-based compensation expense		1,087		1,647		4,824		4,761
Income tax benefit recognized		403		604		1,797		1,747
Stock-based compensation expense, net of income tax	$	684	$	1,043	$	3,027	$	3,014

In the thirteen and thirty-nine weeks ended October 27, 2012 and October 29, 2011, we granted the following equity awards:

	Thirteen Weeks Ended		Thirty-Nine Weeks Ended
	October 27,	October 29,	October 27,	October 29,
	2012	2011	2012	2011
Stock options	1,530	1,341	39,772	34,551
Restricted stock unit awards	2,801	1,000	66,317	103,143
Performance-based restricted stock unit awards	-	-	38,100	53,000
Deferred stock units	252	442	361	1,229

In addition, under our employee stock purchase plan, our employees purchased 1,769 and 6,183 shares of our common stock during the thirteen and thirty-nine weeks ended October 27, 2012, respectively and 2,472 and 7,550 shares of our common stock during the thirteen and thirty-nine weeks ended October 29, 2011, respectively.

The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended October 27, 2012 was $20.72 and $19.45 per share, respectively.  The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $9.25 and $8.20, respectively, and the weighted-average price paid by our employees for shares of our common stock was $49.05 and $43.15, respectively, during the thirteen and thirty-nine weeks ended October 27, 2012.

The weighted-average grant date fair value of stock options granted during the thirteen and thirty-nine weeks ended October 29, 2011 was $13.86 and $12.81 per share, respectively.  The weighted-average grant date fair value of shares of stock purchased through our employee stock purchase plan was $8.95 and $8.23, respectively, and the weighted-average price paid by our employees for shares of our common stock was $28.81 and $29.97, respectively, during the thirteen and thirty-nine weeks ended October 29, 2011.

At October 27, 2012, the total compensation costs, related to nonvested restricted stock unit awards not yet recognized was $9.7 million and the weighted-average period over which such awards are expected to be recognized was 2.50 years.  There are no future compensation costs related to nonvested stock options to be recognized at October 27, 2012.